Complete Filing Data
Fatpipe Inc/UT reported Stockholders Equity Including Portion Attributable To Noncontrolling Interest of $9.56 million for FY2023.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Fatpipe Inc/UT did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 |
|---|---|---|
| Net Income * | $2.0M | $4.4M |
| Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | -$153.8K | $212.0K |
| Selling And Marketing Expense | $3.8M | $3.4M |
| Revenue From Contract With Customer Excluding Assessed Tax | $16.3M | $17.9M |
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | -$153.8K | $212.0K |
| Operating Income Loss | $3.5M | $5.6M |
| Operating Expenses | $11.8M | $11.2M |
| Nonoperating Income Expense | -$184.0K | -$40.0K |
| Interest Expense Nonoperating | $329.9K | $302.1K |
| Income Tax Expense Benefit | $1.3M | $1.4M |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | $3.3M | $5.6M |
| Gross Profit | $15.2M | $16.8M |
| General And Administrative Expense | $3.4M | $3.2M |
| Cost Of Revenue | $1.1M | $1.1M |
| Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest | $1.8M | $4.5M |
| Comprehensive Income Net Of Tax | $1.8M | $4.6M |
| Deferred Income Tax Assets Net | $117.5K | |
| Net Income Loss Attributable To Noncontrolling Interest | -$13.5K | -$87.0K |
| Research And Development Expense |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|---|
| Net Income * | $310.7K | -$43.4K | $741.2K | $84.4K | $1.6M | $625.5K | |
| Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | -$12.8K | -$72.7K | -$55.8K | $304.2K | $100.0K | -$87.3K | |
| Selling And Marketing Expense | $1.3M | $1.2M | $1.1M | $888.5K | $919.4K | $1.0M | |
| Revenue From Contract With Customer Excluding Assessed Tax | $4.1M | $4.0M | $3.9M | $3.1M | $5.6M | $3.8M | |
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | -$12.8K | -$72.7K | -$55.8K | $304.2K | $100.0K | -$87.3K | |
| Operating Income Loss | $402.4K | -$793.00 | $1.0M | $184.8K | $2.3M | $859.8K | |
| Operating Expenses | $3.2M | $3.6M | $2.7M | $2.6M | $3.1M | $2.6M | |
| Nonoperating Income Expense | -$1.6K | -$55.2K | -$46.3K | -$40.4K | -$84.6K | -$87.4K | |
| Interest Expense Nonoperating | $104.1K | $126.0K | $69.9K | $118.1K | $86.4K | $86.0K | |
| Income Tax Expense Benefit | $90.2K | -$12.6K | $215.2K | $60.1K | $551.1K | $163.4K | |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | $400.9K | -$56.0K | $956.4K | $144.4K | $2.2M | $772.5K | |
| Gross Profit | $3.6M | $3.6M | $3.7M | $2.8M | $5.4M | $3.5M | |
| General And Administrative Expense | $828.4K | $1.4M | $587.0K | $573.9K | $1.2M | $581.1K | |
| Cost Of Revenue | $503.8K | $312.9K | $226.9K | $379.9K | $229.3K | $283.7K | |
| Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest | $297.9K | -$116.1K | $685.4K | $388.6K | $1.7M | $521.8K | |
| Comprehensive Income Net Of Tax | $297.9K | -$116.1K | $685.4K | $388.6K | $1.7M | $518.4K | |
| Deferred Income Tax Assets Net | $76.9K | $76.9K | $76.9K | $76.9K | |||
| Net Income Loss Attributable To Noncontrolling Interest | $16.4K | $16.4K | -$16.4K | ||||
| Research And Development Expense | $453.5K | $448.6K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Stockholders Equity * | $13.9M | $9.6M | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $1.1M | ||
| Retained Earnings Accumulated Deficit | $9.0M | ||
| Property Plant And Equipment Net | $75.5K | ||
| Other Liabilities Noncurrent | $116.0K | ||
| Other Assets Noncurrent | $186.9K | ||
| Other Assets Current | $582.4K | ||
| Operating Lease Right Of Use Asset | $205.0K | ||
| Operating Lease Liability Noncurrent | $50.6K | ||
| Operating Lease Liability Current | $164.2K | ||
| Notes And Loans Payable Current | $120.0K | ||
| Liabilities Current | $4.7M | ||
| Liabilities And Stockholders Equity | $21.4M | ||
| Liabilities | $7.4M | ||
| Inventory Net | $113.5K | ||
| Intangible Assets Net Excluding Goodwill | $1.6M | ||
| Contract With Customer Liability Current | $1.5M | ||
| Common Stock Value | $124.5K | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $1.8M | $35.0K | |
| Assets Current | $9.3M | ||
| Assets | $21.4M | ||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $3.3M | ||
| Accrued Liabilities Current | $2.5M | ||
| Accounts Receivable Net Current | $3.2M | ||
| Accounts Payable Current | $417.5K | ||
| Cash | $2.9M | $1.1M | |
| Billed Contract Receivables | $4.4M | ||
| Allowance For Contract Receivables | $272.1K | $262.2K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|---|
| Stockholders Equity * | $21.2M | $21.0M | $20.4M | $15.9M | $16.7M | $16.3M | $14.6M | $14.1M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $6.2M | $6.2M | $5.9M | $2.9M | $1.6M | $845.9K | $767.8K | $1.1M |
| Retained Earnings Accumulated Deficit | $12.1M | $11.8M | $11.8M | $11.1M | ||||
| Property Plant And Equipment Net | $86.7K | $85.1K | $92.8K | $57.8K | ||||
| Other Liabilities Noncurrent | $111.3K | $112.8K | $117.0K | $117.0K | ||||
| Other Assets Noncurrent | $381.4K | $402.8K | $379.2K | $379.1K | ||||
| Other Assets Current | $153.6K | $230.2K | $639.9K | $666.4K | ||||
| Operating Lease Right Of Use Asset | $1.2M | $1.3M | $1.4M | $1.5M | ||||
| Operating Lease Liability Noncurrent | $800.0K | $905.4K | $1.0M | $1.1M | ||||
| Operating Lease Liability Current | $394.1K | $384.7K | $376.8K | $366.7K | ||||
| Notes And Loans Payable Current | $417.3K | $577.7K | $731.2K | $463.4K | ||||
| Liabilities Current | $6.1M | $6.1M | $6.3M | $6.5M | ||||
| Liabilities And Stockholders Equity | $32.4M | $32.2M | $32.0M | $28.3M | ||||
| Liabilities | $11.2M | $11.3M | $11.6M | $12.4M | ||||
| Inventory Net | $167.3K | $328.7K | $408.2K | $419.7K | ||||
| Intangible Assets Net Excluding Goodwill | $764.8K | $860.7K | $964.2K | $1.0M | ||||
| Contract With Customer Liability Current | $1.1M | $1.1M | $1.2M | $1.4M | ||||
| Common Stock Value | $131.2K | $131.2K | $130.3K | $130.3K | ||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $3.0M | -$344.7K | ||||||
| Assets Current | $16.6M | $16.6M | $16.3M | $13.0M | ||||
| Assets | $32.4M | $32.2M | $32.0M | $28.3M | ||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $3.0M | $3.0M | $3.0M | $3.1M | ||||
| Accrued Liabilities Current | $3.9M | $3.7M | $3.7M | $3.9M | ||||
| Accounts Receivable Net Current | $4.4M | $4.3M | $4.0M | $3.8M | ||||
| Accounts Payable Current | $352.2K | $294.8K | $310.2K | $437.3K | ||||
| Cash | ||||||||
| Billed Contract Receivables | $5.5M | $5.4M | $5.2M | |||||
| Allowance For Contract Receivables | $33.8K | $49.4K |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 |
|---|---|---|
| Net Cash Provided By Used In Operating Activities | -$504.1K | -$363.4K |
| Net Cash Provided By Used In Investing Activities | -$19.8K | -$19.2K |
| Increase Decrease In Other Noncurrent Assets | $192.2K | $78.8K |
| Increase Decrease In Other Current Assets | $84.0K | -$420.9K |
| Increase Decrease In Operating Lease Liability | $15.6K | $410.4K |
| Increase Decrease In Inventories | $306.2K | -$242.4K |
| Increase Decrease In Contracts Receivable | $3.4M | $6.8M |
| Increase Decrease In Contract With Customer Liability | -$160.8K | -$330.0K |
| Increase Decrease In Accrued Liabilities | $1.5M | $929.0K |
| Increase Decrease In Accounts Receivable | $1.1M | $689.5K |
| Increase Decrease In Accounts Payable | $19.7K | $176.4K |
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | -$153.8K | $212.0K |
| Depreciation Depletion And Amortization | $545.7K | $699.3K |
| Net Cash Provided By Used In Financing Activities | $2.5M | $205.7K |
| Increase Decrease In Other Noncurrent Liabilities | ||
| Share Based Compensation |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q2 2024 |
|---|---|---|---|
| Net Cash Provided By Used In Operating Activities | -$508.6K | -$252.5K | |
| Net Cash Provided By Used In Investing Activities | -$42.4K | -$5.0K | |
| Increase Decrease In Other Noncurrent Assets | $79.00 | -$239.00 | |
| Increase Decrease In Other Current Assets | -$26.5K | $66.5K | |
| Increase Decrease In Operating Lease Liability | $9.5K | -$21.9K | |
| Increase Decrease In Inventories | -$11.5K | -$25.0K | |
| Increase Decrease In Contracts Receivable | $757.6K | $546.4K | |
| Increase Decrease In Contract With Customer Liability | -$140.5K | -$190.2K | |
| Increase Decrease In Accrued Liabilities | -$196.2K | $225.3K | |
| Increase Decrease In Accounts Receivable | $201.8K | $301.1K | |
| Increase Decrease In Accounts Payable | -$127.0K | -$168.8K | |
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | -$55.8K | -$87.3K | |
| Depreciation Depletion And Amortization | $92.0K | $133.5K | |
| Net Cash Provided By Used In Financing Activities | $3.6M | ||
| Increase Decrease In Other Noncurrent Liabilities | $51.00 | -$148.00 | |
| Share Based Compensation | $625.2K |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 |
|---|---|---|
| Weighted Average Number Of Shares Outstanding Basic | 12.9M | 12.4M |
| Weighted Average Number Of Diluted Shares Outstanding | 12.9M | 12.4M |
| Earnings Per Share Diluted | $0.15 | $0.35 |
| Earnings Per Share Basic | $0.15 | $0.35 |
| Common Stock Shares Authorized | 15.0M | |
| Common Stock Par Or Stated Value Per Share | $0.00 | |
| Common Stock Shares Outstanding | 12.4M | |
| Common Stock Shares Issued | 12.4M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|---|
| Weighted Average Number Of Shares Outstanding Basic | 13.9M | 13.9M | 13.8M | 13.0M | 12.7M | 12.4M | |
| Weighted Average Number Of Diluted Shares Outstanding | 13.9M | 13.9M | 13.8M | 13.0M | 12.7M | 12.4M | |
| Earnings Per Share Diluted | $0.02 | $0.00 | $0.05 | $0.01 | $0.13 | $0.05 | |
| Earnings Per Share Basic | $0.02 | $0.00 | $0.05 | $0.01 | $0.13 | $0.05 | |
| Common Stock Shares Authorized | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M | ||
| Common Stock Par Or Stated Value Per Share | $0.01 | $0.01 | $0.01 | $0.01 | $0.00 | ||
| Common Stock Shares Outstanding | 13.9M | 13.9M | 13.8M | 13.0M | |||
| Common Stock Shares Issued | 13.9M | 13.9M | 13.8M | 13.0M |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 |
|---|---|---|
| Foreign Currency Transaction Gain Loss Before Tax | $101.4K | $27.2K |
| Employee Cost | $2.8M | $2.9M |
| Product Development | $1.8M | $1.7M |
| Long Term Notes And Loans | $2.5M | |
| Investment Income Interest | $42.7K | $27.3K |
| Interest Paid Net | $329.9K | $302.1K |
| Additional Paid In Capital | $1.5M | |
| Contracts Recevable Non Current Net | $10.0M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|---|
| Foreign Currency Transaction Gain Loss Before Tax | $61.4K | $27.9K | $17.8K | $60.5K | $17.4K | -$27.4K | |
| Employee Cost | $617.0K | $562.7K | $593.2K | $673.0K | $564.3K | $587.2K | |
| Product Development | $489.2K | $474.5K | $435.4K | $423.5K | |||
| Long Term Notes And Loans | $4.2M | $4.2M | $4.2M | $4.6M | |||
| Investment Income Interest | $41.1K | $5.8K | $15.3K | $26.1K | |||
| Interest Paid Net | $69.9K | $302.1K | |||||
| Additional Paid In Capital | $6.0M | $6.1M | $5.4M | $1.6M | |||
| Contracts Recevable Non Current Net | $13.0M | $12.8M | $12.3M |
Most recent annual filing with the SEC: June 30, 2025
Data sourced from SEC EDGAR public filings as of August 4, 2026.